Dietary Ingredient Advisory List Yet To Fulfill Potential For US FDA
Executive Summary
"We haven't utilized the ingredient advisory list quite as much as I'd like to see. But it's something we'll be working on this year,” says Cara Welch, acting director of FDA’s Office of Dietary Supplement Programs.
You may also be interested in...
US Firm Removed From Warnings About Botanicals ‘Removed’ From Lawful Use In Supplements
FDA retracts warning against Glanbia Performance Nutrition Manufacturing about selling adulterated dietary supplements.
US FDA Warns About Botanicals Determined As Unlawful Being Used As Dietary Ingredients
One or more of 5-alpha-hydroxy laxogenin, higenamine, hordenine and octopamine is used by 11 firms FDA warned in products labeled as supplements and marketed as beneficial for weight loss and strength training.
Welch Leads US FDA’s Dietary Supplement Office
Center for Food Safety and Applied Nutrition says Cara Welch selected to fill Office of Dietary Supplement Programs director post. She’ll move up from ODSP deputy director on 14 March.